Effect of Transauricular Vagal Stimulation on Cardiac Function After Spinal Cord Injury
Key facts
- Who runs it
- Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Where
- Ankara, TürkiyeSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 20 Mar 2024
- Planned end
- 30 Sept 2025
- Type of study
- Interventional, 3 groups
- Treatments tested
- Active Transauricular Vagus Nerve Stimulation
- Sham Transauricular Vagus Nerve Stimulation
- Record updated
- 6 June 2025
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Aged between 18-60
- Having a traumatic spinal cord injury
- Cervical spinal cord injury patients with a history of autonomic dysreflexia
- At least 6 months after the injury
- Signing an informed consent form showing consent to participate in the study
Who cannot take part
- Having a cardiac or neural pacemaker
- Clinical coronary artery disease confirmed by invasive or coronary computed tomographic angiography
- History of acute coronary syndrome (unstable angina, myocardial infarction)
- Documented arrhythmia and/or use of antiarrhythmic drugs on ECG
- Diagnosis of hypertension and use of antihypertensive drugs
- Presence of pregnancy
- Damaged skin lesion in the application area
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where in Türkiye
- SBÜ Gaziler Fizik Tedavi ve Rehabilitasyon Eğitim ve Araştırma HastanesiAnkara, TürkiyeContact: Ayşenur Şimşek YağlıoğluTaking people
About the trial
What the trial wants to find out
The aim of this study is to investigate the effect of transauricular vagal nerve stimulation (taVNS) on cardiac autonomic functions in patients with spinal cord injury (SCI).
The 3 groups in the trial
- Cervical spinal cord injury - Active taVNSTreatment being tested
The study included 30 traumatic spinal cord injury (SCI) patients who fulfilled the criteria. Patients were divided into groups as group I cervical complete SCI patients in active transaurikular vagal nerve stimülation (taVNS) group (n:10), group II cervical complete SCI patients in sham taVNS group (n:10) and group III lumbar SCI patients (diagnosed with cauda equina syndrome) in active taVNS group (n:10).
Treatment: Active Transauricular Vagus Nerve Stimulation
- Cervical spinal cord injury - Sham taVNSTreatment being tested
The study included 30 traumatic SCI patients who fulfilled the criteria. Patients were divided into groups as group I cervical complete SCI patients in active taVNS group (n:10), group II cervical complete SCI patients in sham taVNS group (n:10) and group III lumbar SCI patients (diagnosed with cauda equina syndrome) in active taVNS group (n:10).
Treatment: Sham Transauricular Vagus Nerve Stimulation
- Lumbar spinal cord injury (Cauda Equina Syndrome)- Active taVNSTreatment being tested
The study included 30 traumatic spinal cord injury (SCI) patients who fulfilled the criteria. Patients were divided into groups as group I cervical complete SCI patients in active taVNS group (n:10), group II cervical complete SCI patients in sham taVNS group (n:10) and group III lumbar SCI patients (diagnosed with cauda equina syndrome) in active taVNS group (n:10).
Treatment: Active Transauricular Vagus Nerve Stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Effect of Transauricular Vagal Nerve Stimulation (taVNS) on Cardiac Autonomic Functions in Patients With Spinal Cord Injury
- Fit questions
- Built from NCT07007884, who can take part
- Record updated
- 6 June 2025